Neil Gallagher - 01 May 2025 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Reporting relationship: Director
Issuer ticker: FHTX
Reported as of: 01 May 2025
Net transaction value: +$208,000
SEC form: 4
Accepted by SEC: 02 May 2025, 16:04:44 UTC
Prior SEC filing: 12 Feb 2025
Source filing: View source filing
Reporting owner signature: /s/ Michael LaCascia, Attorney-in-Fact for Neil Gallagher

Key filing fact

Neil Gallagher filed Form 4 for Foghorn Therapeutics Inc. (FHTX) on 02 May 2025.

Key facts

This page summarizes Neil Gallagher's Form 4 filing for Foghorn Therapeutics Inc. (FHTX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 02 May 2025, 16:04.

Change

Previous filing in this sequence was filed on 12 Feb 2025.
Current net transaction value: +$208,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001972849 Primary reporting owner

Gallagher Neil

Relationship: Director
Address: 500 TECHNOLOGY SQUARE, SUITE 700, CAMBRIDGE
Signature: /s/ Michael LaCascia, Attorney-in-Fact for Neil Gallagher
Signature date: 02 May 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

FHTX transaction Derivative

Stock Options (Right to buy)

Award

Transaction value: $208,000
Shares: +50,000
Change %
Price: $4.16
Shares after: 50,000
Date: 01 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 50,000
Exercise price: $4.16
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The options will vest as to one-third of the underlying shares of common stock on each of the first three anniversaries of the date of grant, subject to the recipient's continuing service on the board of directors.